Last updated: Nov 20, 2026, 12:00 AM

Egide S.A. Exchange (PA, EUR)

ALGID.PA

0.63
-0.02 (-3.69%)
TechnologyElectronic Components
Invest Today
Invest Today
1 year return (CAGR)
63.02%
3 year return (CAGR)
-0.32%
5 year return (CAGR)
-13.38%
10 year return (CAGR)
-13.55%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
12.38M
Price/Sales
0.20
Ent value
27.40M
Price/Book
5.35
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open0.66
Daily high0.66
Daily low0.62
Daily Volume1K
All-time high449.01
1y analyst estimate1.21
Beta0.28
EPS (TTM)-0.26
Dividend per share0.00
Ex-div date-
Next earnings date27 Apr 2026

Ready to capitalize on Egide S.A.'s growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
ALGID.PAS&P500
Current price drop from All-time high-99.86%-8.11%
Highest price drop-99.95%-56.47%
Date of highest drop16 Oct 20249 Mar 2009
Avg drop from high-92.10%-10.64%
Avg time to new high96 days12 days
Max time to new high6492 days1805 days
News
Aktieselskabet Schouw has delivered a strong share price performance in recent years, which puts a spotlight on whether the current DKK 900.0 level is adequately supported by its earnings power. With ...
November 22, 2026
The recent AI selloff that dragged the Nasdaq and S&P 500 into correction territory has knocked a lot of richly valued stories off their pedestal, which leaves quieter cash generators looking more int...
November 21, 2026
Glenveagh Properties has delivered a powerful long term return, yet the recent share price leaves a simple question hanging for investors who care about fundamentals. Are the cash flows that the busin...
November 21, 2026
Bayer (XTRA:BAYN) has just started U.S. commercial rollout of SUNHARBO, a first in class oral Factor XIa inhibitor for secondary stroke prevention. This gives investors a fresh data point on its pharm...
November 21, 2026
Bayer has had a strong run over the past year, which puts fresh attention on whether the current share price lines up with what the business is generating in sales. With investors weighing both legal ...
November 21, 2026
Bayer (XTRA:BAYN) has launched SUNHARBO, a Factor XIa inhibitor, in the U.S. following recent FDA approval for stroke risk reduction. SUNHARBO is the first medicine of its class cleared in the U.S. fo...
November 21, 2026
Chocoladefabriken Lindt & Sprüngli has seen its share price fall sharply over the past year, which naturally puts the focus on whether the current valuation is still supported by the cash the business...
November 21, 2026
When the European Central Bank shuffles its top seats while inflation holds at 4% and questions swirl around French debt, bond markets do not sit quietly. Pricing of risk can reset fast, and with it t...
November 21, 2026
Alten has seen its share price move around over recent years, and that raises a simple but important question for investors. Is the current €82.45 price fairly reflecting the cash flows that the busin...
November 21, 2026
CTS Eventim KGaA reported third quarter 2026 sales of €809.12 million and net income of €50.26 million, with basic EPS from continuing operations at €0.52, while nine month 2026 sales reached €2,321.9...
November 21, 2026